NTERCEPT PHARMACEUTICALS $33.89

up +0.67


20/5/2013 12:20 PM  |  NASDAQ : ICPT  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
4/9/2013 Shapiro David CMO and EVP - Development -100 $34.38 -4.55%
4/9/2013 Shapiro David CMO and EVP - Development -200 $34.25 -5.41%
4/9/2013 Shapiro David CMO and EVP - Development -100 $34.29 -2.86%
4/9/2013 Shapiro David CMO and EVP - Development -300 $34.30 -8.82%
4/9/2013 Shapiro David CMO and EVP - Development -300 $34.31 -9.68%
4/9/2013 Shapiro David CMO and EVP - Development -100 $34.32 -3.57%
4/9/2013 Shapiro David CMO and EVP - Development -100 $34.33 -3.70%
4/9/2013 Shapiro David CMO and EVP - Development -200 $34.35 -7.69%
4/9/2013 Shapiro David CMO and EVP - Development -200 $34.38 -8.33%
4/9/2013 Shapiro David CMO and EVP - Development -50 $33.86 -1.33%
4/9/2013 Duncan Barbara Gayle Chief Financial Officer -2,676 $34.57 -41.23%
4/9/2013 Shapiro David CMO and EVP - Development -2,100 $34.50 -100.00%
4/9/2013 Shapiro David CMO and EVP - Development -3,049 $34.57 -37.58%
4/9/2013 Pruzanski Mark President and CEO -10,774 $34.57 -2.66%
4/9/2013 Pruzanski Mark President and CEO -10,774 $34.57 -2.66%
10/16/2012 ORBIMED ADVISORS LLC Substantial Shareholder 333,334 $15.00 18.34%
10/16/2012 SILVERSTEIN JONATHAN Senior Executive Officer 333,334 $15.00 18.34%
10/16/2012 SILVERSTEIN JONATHAN Senior Executive Officer 333,334 $15.00 18.34%
10/16/2012 ORBIMED ADVISORS LLC Substantial Shareholder 333,334 $15.00 18.34%
10/16/2012 SILVERSTEIN JONATHAN Senior Executive Officer 333,334 $15.00 18.34%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ICPT), click here.
Marketplace
Trading Center